spacer
home > pmps > winter 2002 > clinical trial supplies - the essential link
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Clinical Trial Supplies - The Essential Link

Strategically positioned within the bio/pharma development pipeline, at the very centre of the clinical trials process, resides a 'hardware' component: the test article or clinical trial material (CTM).

The outcome of field tests for this essential link in the chain is crucial to future success of investment in R&D. Given the strategic importance of procuring CTM, it's not surprising that the complex clinical trial supplies (CTS) business absorbs a hefty chunk of a sponsor's development budget. Trials can no longer be set up in-house using homemade trial packs, labelled by hand and randomly assigned to patients with little or no control. Today's CTS business is a slick, highly sophisticated operation which is considered a microcosm of the wider pharmaceutical industry. This article will review aspects of the modern CTS business.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Patricia Lobo, Editor of PMPS and Senior Consultant in CTS and Manufacturing at Technomark Consulting Services Ltd
spacer
Dr Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Pharmapack Europe 2020 Award Winners Announced

Exhibitor Innovations 1. Best Innovation in Drug Delivery Device (injectable): The Connect™ Auto-Sensing Injection System by Credence MedSystems 2. Best Innovation in Drug Delivery Device (respiratory): Safe'n'Spray™ by NEMERA 3. Best Innovation in Primary Packaging (solid dosage): Push Tab® loop by Huhtamaki Flexible Packaging 4. Best Innovation in Primary Packaging (liquid dosage): Pourer “Lotus” by PACKSYS GmbH 5. Best Innovation in Secondary Packaging: Patient Support App by Rondo 6. Best Innovation in Machinery: Quantifeel Quality Assurance Platform by Smart Skin Technologies
More info >>

White Papers

The BioPharmaSpec Approach”: Mass Spectrometry Based Host Cell Protein Identification and Quantitation

BioPharmaSpec

1. Introduction As part of the development of any biopharmaceutical product, the impurities present must be examined, minimized and where possible characterized (1). These impurities fall into two broad categories: product-related impurities (derived specifically from the drug product itself) and process-related impurities (derived from material associated with the production, processing or purification of the sample). Host cell proteins (HCPs) are process-related impurities that require specific analysis due to the multitude of naturally occurring proteins expressed in the production cell line.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement